Stomach Gastric Juice
Stomach Gastric Juice - Related Videos
05:13
Gastric Fundic Glands Isolation: A Method to Isolate Fundic Glands from Human Stomach Tissue
0 Views •
2023
This video describes a method to isolate gastric epithelial cells from the human fundic tissue. The isolated epithelial cells can be used as an in vitro model to study their regulatory roles in gastric physiology and pathophysiology.
05:18
Roux-en-Y Gastric Bypass Procedure: A Bariatric Surgical Procedure for Gastric Resectioning in Murine Model
0 Views •
2025
This video describes a bariatric surgery-Roux-en-Y procedure. This involves the cutting of the jejunum- the middle portion of the intestine- to generate two intestinal limbs. The biliary limb is attached to the existing intestinal loop and the alimentary limb is attached to the stomach, creating a gastric bypass. The gastric bypass created here helps to decrease the nutrient uptake and efficiently reduces body weight.
10:12
Gross Dissection of the Stomach of the Lobster, Homarus Americanus
0 Views •
Cited by 5 •
2009
We describe the gross dissection of the stomach of the American lobster (Homarus americanus).
02:49
Quantification of Helicobacter pylori Load in an Infected Mouse Stomach
0 Views •
2025
In this video, we describe a protocol to quantify Helicobacter pylori load in mouse stomach tissues post-infection to confirm its colonization.
05:49
Murine Vertical Sleeve Gastrectomy: A Surgical Procedure to Downsize Stomach in Experimental Mouse Models
0 Views •
2023
In this video, a vertical sleeve gastrectomy procedure is performed on an experimental mouse model. This procedure helps remove a significant portion of the stomach along its greater curvature.
FAQs
The H+/K+-ATPase in parietal cells releases hydrochloric acid into the stomach, creating the acidic environment required for key digestive and protective functions. This acidity supports conversion of pepsinogen into active pepsin and helps limit ingested microbes. Because the pump directly contributes to acid secretion, it is an important pharmacological target.
Chief cells release pepsinogen, which remains inactive until it encounters the acidic environment of the stomach. Acid-dependent activation produces pepsin, the enzyme that initiates protein digestion. This sequence links secretion to the stomach’s chemical conditions and ensures that protein-processing activity occurs where gastric acidity can support it.
Mucus and bicarbonate provide protective components that help shield the stomach lining while acidic gastric juice remains present in the lumen. Their role is important because the same secretion that supports digestion and microbial control could otherwise contribute to acid-related injury. Pharmacology therefore considers both acid secretion and mucosal protection.
Proton pump inhibitors, histamine H2-receptor antagonists, and antacids are used to reduce acid-related injury associated with stomach gastric juice. The overview identifies these as major pharmacological approaches, although they represent different treatment classes. Their shared clinical purpose is to lessen the harmful consequences of excessive or damaging gastric acidity.
Gastric juice is clinically relevant because its acidity can contribute to acid-related injury in conditions such as peptic ulcers and gastroesophageal reflux disease. Understanding secretion by parietal cells, activation of pepsin, and protection by mucus and bicarbonate gives pharmacologists a basis for selecting acid-reducing treatments for these disorders.
Studying gastric juice connects normal stomach physiology with drug action and therapeutic decision-making. It explains why the H+/K+-ATPase, acid-dependent pepsin activation, and protective mucus-bicarbonate components matter when evaluating treatments. This context supports the use of proton pump inhibitors, H2-receptor antagonists, and antacids to address acid-related injury.